Biogen Inc (BIIB)
256.08
-0.98
(-0.38%)
USD |
NASDAQ |
Oct 02, 10:20
Biogen Net Income (TTM): 2.665B for June 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
June 30, 2023 | 2.665B |
March 31, 2023 | 3.131B |
December 31, 2022 | 3.047B |
September 30, 2022 | 2.865B |
June 30, 2022 | 2.059B |
March 31, 2022 | 1.450B |
December 31, 2021 | 1.556B |
September 30, 2021 | 1.546B |
June 30, 2021 | 1.918B |
March 31, 2021 | 3.012B |
December 31, 2020 | 4.001B |
September 30, 2020 | 5.082B |
June 30, 2020 | 5.927B |
March 31, 2020 | 5.879B |
December 31, 2019 | 5.888B |
September 30, 2019 | 5.396B |
June 30, 2019 | 5.294B |
March 31, 2019 | 4.667B |
December 31, 2018 | 4.431B |
September 30, 2018 | 3.186B |
June 30, 2018 | 2.968B |
March 31, 2018 | 2.964B |
December 31, 2017 | 2.539B |
September 30, 2017 | 3.486B |
June 30, 2017 | 3.292B |
Date | Value |
---|---|
March 31, 2017 | 3.480B |
December 31, 2016 | 3.703B |
September 30, 2016 | 3.885B |
June 30, 2016 | 3.818B |
March 31, 2016 | 3.695B |
December 31, 2015 | 3.547B |
September 30, 2015 | 3.599B |
June 30, 2015 | 3.490B |
March 31, 2015 | 3.277B |
December 31, 2014 | 2.935B |
September 30, 2014 | 2.509B |
June 30, 2014 | 2.139B |
March 31, 2014 | 1.916B |
December 31, 2013 | 1.862B |
September 30, 2013 | 1.697B |
June 30, 2013 | 1.608B |
March 31, 2013 | 1.504B |
December 31, 2012 | 1.380B |
September 30, 2012 | 1.388B |
June 30, 2012 | 1.342B |
March 31, 2012 | 1.243B |
December 31, 2011 | 1.234B |
September 30, 2011 | 1.174B |
June 30, 2011 | 1.077B |
March 31, 2011 | 1.082B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
1.450B
Minimum
Mar 2022
5.927B
Maximum
Jun 2020
3.674B
Average
3.131B
Median
Mar 2023
Net Income (TTM) Benchmarks
Eli Lilly and Co | 6.498B |
Pfizer Inc | 21.47B |
Sage Therapeutics Inc | -591.62M |
Reata Pharmaceuticals Inc | -87.62M |
AbbVie Inc | 8.685B |